Labcorp announces key appointments to oncology leadership team

BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 9, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced the appointments of Prasanth Reddy , MD, MPH, and Robert Phillips , PhD, to its oncology team, advancing Labcorp’s leadership position and capabilities in cancer diagnosis, treatment, and drug development.

The Health Plan expands access to Labcorp, its exclusive independent laboratory, by opening a new patient service center in Wheeling

WHEELING, WEST VIRGINIA—February 4, 2021 – The Health Plan of West Virginia, Inc. today announced the opening of a new Labcorp patient service center (PSC) in Wheeling, WV. 

Labcorp named to FORTUNE® Magazine’s 2021 ‘World’s Most Admired Companies,’ making the annual list for the third time

BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 1, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has been named to FORTUNE® magazine's 2021 List of World’s Most Admired Companies, making the annual list for the third time.

Labcorp earns 100 percent on Human Rights Campaign Foundation’s annual scorecard on LGBTQ workplace equality

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 28, 2021-- Labcorp® (NYSE: LH), a leading global life sciences company, today announced that it received a perfect score of 100 percent on the Human Rights Campaign Foundation’s 2021 Corporate Equality Index (CEI), the nation’s premier benchmarking survey and report measuring corporate policies and practices related to LGBTQ workplace equality. This is the fourth consecutive year Labcorp has received this designation.

Guideline on testing activated protein C resistance (APC-R)

Comparison of the ST genesia thrombin generation assay and the Thrombinoscope™ CAT (Diagnostica Stago, Inc.)